Retatrutide

Retatrutide is a multi-agonist peptide designed to activate GIP, GLP-1, and glucagon receptors, giving it a unique profile among incretin-based compounds. Early research has explored its potential to influence metabolic function, body-weight regulation, and energy balance by acting on multiple hormonal pathways simultaneously. Studies suggest this triple-agonist approach may enhance glucose control, support fat-loss mechanisms, and impact overall metabolic signaling more robustly than single-pathway peptides. Retatrutide continues to be of high interest in metabolic and endocrine research due to its broad receptor activity and emerging clinical data. For research use only.